Vimarsana
Biggest News Aggregation in the World

Page 12 - Bart De Strooper News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Bart De Strooper. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Bart De Strooper Today - Breaking & Trending Today

Data shows drug slowing Alzheimer's but doubts over effect remain | Health News - Vimarsana News

Data shows drug slowing Alzheimer's but doubts over effect remain | Health News

Lecanemab modestly slows disease’s inevitable worsening, but it remains unclear how much of a difference it will make.

The effectiveness of an anti-Alzheimer's drug confirmed by the results of a clinical study - Vimarsana News

The effectiveness of an anti-Alzheimer's drug confirmed by the results of a clinical study

An experimental treatment for Alzheimer's disease developed by Eisai and Biogen has slowed the decline of cognitive abilities in patients who participated in a clinical trial, according to...

Alzheimer's Drug Data Demonstrates Some Relief And Also Serious Risks - Vimarsana News

Alzheimer's Drug Data Demonstrates Some Relief And Also Serious Risks

Experts hailed full data Wednesday showing a new drug can slow cognitive decline in Alzheimer's patients, but warned improvements were comparatively small and the treatment can have serious side effects.

Muna Therapeutics gets $4.9M grant for Parkinson's research - Vimarsana News

Muna Therapeutics gets $4.9M grant for Parkinson's research

Muna Therapeutics has been awarded a $4.9 million grant from The Michael J. Fox Foundation for Parkinson’s Research.

LifeArc and UK DRI launch new partnership to accelerate development of new treatments for dementia - Vimarsana News

LifeArc and UK DRI launch new partnership to accelerate development of new treatments for dementia

LifeArc and the UK Dementia Research Institute (UK DRI) have today launched a new partnership to accelerate development of new diagnostic tests, treatments, and devices from scientific research discoveries to benefit people with dementia, which around 900,000 people in the UK are living with.